While heart failure and myocarditis are caused by metabolites of CP8, atrioventricular block and tachyarrhythmias might be associated with the mechanisms of arrhythmia occurrence under CP influence on a cellular level, particularly when small doses of the drug are taken (i.e., less than 100 mg/kg). This evidence concerns the gene CP and atrioventricular block.